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Abstract
Primary squamous cell carcinoma of the breast is a very rare and aggressive malignancy, and very few have been reported in the litera-
ture. Here we report a case of an acantholytic variant of a squamous cell carcinoma of the breast in a 60-year-old woman who presented 
with a lump in the right breast. Histogenesis is controversial as to whether a pure form of squamous cell carcinoma exists or if these 
malignancies represent an extreme squamous metaplasia within an adenocarcinoma. Prognosis and management is uncertain due to its 
rarity and controversy over its definition.
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Key messages: Reported incidence of acantholytic variant of squamous cell carcinoma is only 0.1%. Primary squamous cell carcinoma 
should always be distinguished from other types of carcinoma as they require a different line of treatment.
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Introduction
Pure squamous cell carcinoma (SCC), an extremely rare neoplasm, which according to the WHO classification [1] is listed under metaplastic 
breast carcinoma. Two variants of SCC are acantholytic variant of a squamous cell carcinoma (AVSCC) characterized by lack of cohesive-
ness of the tumour cells resulting in a pseudovascular or pseudoglandular appearance [2] and adenosquamous carcinoma [3]. The age of 
patients ranges from 29 to 90 years with a median age of 52 year [4]. The reported incidence is of 0.1% of all ductal carcinomas [5]. Here we 
report a rare case of an acantholytic variant of squamous cell carcinoma, the rarity of which has been documented by Lee et al [6] who noted 
that up to now only nine cases of AVSCC of breast have been reported.
Case history: A-60-year-old woman presented with 7 × 4 cm lump just below the nipple and areola in her right breast which had developed 
over the previous two months. There was no retraction or discharge from the nipple and the skin over the lump was normal. Two ipsilateral 
axillary lymph nodes were enlarged. Left breast examination was normal. Her past and family history were not significant. An ultrasound 
examination revealed solid hypoechogenic masses with complex cystic components. FNAC yielded 7 ml of dirty fluid from the lump. Air-
dried smears were prepared from the centrifuged aspirated fluid and stained with haematoxylin and eosin. The stained smears showed 
individual malignant squamous cells and loosely cohesive clusters of cells. Cells were polygonal in shape with hyperchromatic enlarged 
nuclei and coarse chromatin. Keratinous debris was present in the background. A differential diagnosis of primary and metastatic squa-
mous cell carcinoma was made. A total body computed tomography (CT) scan and bone scan, carried out to identify other sites of squa-
mous cell carcinoma in the body, were normal. The patient underwent MRM with ipsilateral axillary clearance. Macroscopically the primary 
tumour was located 0.5 cm below nipple and areola and measured 7 × 4 × 3 cm. A cross section of the mass showed a cystic area with 
necrosis in the upper portion and a grey white solid area just below it (Figure 1). Two axillary lymph nodes were isolated. Histopathology 
showed cells arranged in pseudoglandular pattern, and at places cells were arranged in loose cohesive clusters representing acantholysis 
(Figure 2a–c). The cells were polygonal, with nuclear pleomorphism, coarse chromatin and dense eosinophilic cytoplasm. Intermingling 
stroma had lymphocytic infiltration. There was an associated intraductal component which showed ducts lined by squamous cells with 
central region of necrosis similar to comedo necrosis. The necrotic component was comprised of keratinous debris (Figure 3). Extensive 
sampling of nipple, areola and skin was carried out but these regions were completely free of neoplastic cells. There was no associated 
invasive ductal carcinoma or any other feature of metaplastic carcinoma. Only one lymph node was metastatic.
Discussion
Pure primary squamous carcinoma is a rare and aggressive form of metaplastic carcinoma of breast. Macia and colleagues defined pure 
squamous cell carcinoma with following criteria [7]
Figure 1 Microphotograph of cut section of the mass showing a cystic area with necrosis in upper portion and a grey white solid area just 
below it (H&E stain).www.ecancermedicalscience.com 3
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1.  No other neoplastic components such as ductal or mesenchymal elements are present in the tumour.
2.  The tumour origin is independent of the overlying skin and nipple.
3.  Absence of an associated primary squamous cell carcinoma in a second site.
Figure 2 (a) Microphotograph showing malignant squamous cells in pseudoglandular pattern (H&E stain). (b) Microphotograph showing malig-
nant squamous cells in pseudoglandular pattern (H&E stain). (c) Microphotograph showing acantholysis of squamous cells (H&E stain).
Figure 3 Microphotograph showing intraductal component which showed ducts lined by squamous cells with central region of necrosis (H&E 
stain).ecancer 2011, 5:214
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According to Rosen et al [8], the presence of in situ squamous carcinoma in the ducts is a must for the diagnosis of primary squamous 
cell carcinoma. They have defined squamous carcinoma as a lesion in which more than 90% of the neoplasm is comprised of squamous 
carcinoma or its variant. In the case reported here, the tumour had an intraductal component and the carcinoma was comprised of more 
than 90% of malignant squamous cells. Rosen et al [8] have also mentioned that cystic degeneration was associated with primary squa-
mous cell carcinoma and not with metastatic squamous cell carcinoma. This further supported our diagnosis as we aspirated 7 ml of fluid 
in FNAC, and cystic degeneration was evident macroscopically. The histogenesis of this type of tumour is still unclear. It could represent 
an extreme form of a squamous metaplasia within an adenocarcinoma or alternatively it may have arisen directly from the epithelium of 
the mammary ducts [9]. Immunohistochemically, AVSCC is characterized by high proliferative activity, an uncommon cytokeratin expres-
sion profile, reduced E-cadherin staining and overexpression of p53 and the epithelial growth factor receptor (EGFR) [10]. In our case, 
immunohistochemisry was positive for high molecular weight keratin.
Arrangoiz et al [4] have reported that axillary lymph node metastases occur rarely and when they do are usually associated with meta-
plastic squamous cell carcinoma arising as an invasive ductal carcinoma. In this case study, one of the two lymph nodes also showed 
metastasis with morphological features similar to tumour in breast.
Prognosis appears to be dependent on tumour size and tumour stage but well-documented reports are still lacking. It is hard to tell 
whether the amount of the acantholytic component affects the prognosis or not, because previous reports did not describe the exact 
proportion of each component in acantholytic variant of squamous cell carcinoma [2].
Conclusion
Acantholytic variant of squamous cell carcinoma, a newly defined entity is very rare and aggressive in nature. Such tumours should be 
distinguished from metaplastic adenocarcinoma with squamoid differentiation since there is no effective adjuvant or neoadjuvant therapy 
available for its treatment. In the case presented here, the patient was referred to another centre for treatment as she was also triple nega-
tive for receptor expression and so we could not follow-up the patient.
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